Valencian Community

Valencia Digital Summit brings together 12,000 professionals from 91 countries for its sixth edition

Retrieved on: 
Monday, October 30, 2023

The sixth edition of Valencia Digital Summit has yet again exceeded all expectations by bringing together a staggering 12,000 professionals from 91 countries.

Key Points: 
  • The sixth edition of Valencia Digital Summit has yet again exceeded all expectations by bringing together a staggering 12,000 professionals from 91 countries.
  • Valencia Digital Summit is committed to advancing the Valencian innovation ecosystem and driving the evolution of startups into competitive scaleups.
  • Furthermore, Valencia Digital Summit hosted the session 'New Benchmarks in The Ecosystem: Premios EmprendeXXI Investors Day & Kick Off New Edition', featuring the 'Investors Day Premios EmprendeXXI'.
  • Exploring key sectors of the Valencian economy, a variety of thematic side-events took place within the framework of Valencia Digital Summit.

Five Ovation-Supported Research Abstracts Presented at ASRM 2023

Retrieved on: 
Wednesday, October 18, 2023

Nashville, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Ovation® Fertility teams presented three poster and two oral presentations at the 2023 ASRM Scientific Congress & Expo, which takes place in New Orleans, Louisiana, October 14-18, 2023.

Key Points: 
  • Nashville, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Ovation® Fertility teams presented three poster and two oral presentations at the 2023 ASRM Scientific Congress & Expo, which takes place in New Orleans, Louisiana, October 14-18, 2023.
  • “ASRM is an event that we look forward to and work toward every year because it provides us so many opportunities to learn and share with other experts in reproductive medicine,” says Matthew “Tex” VerMilyea, Ph.D., HCLD/CC, Ovation’s vice president of scientific advancement.
  • “We are very excited to have been invited to showcase many of our latest research findings, produced in collaboration with our physician partners and key suppliers of advanced reproductive technologies, such as artificial intelligence.”
    This year’s Ovation-supported presentations covered advances in intracytoplasmic sperm injection (ICSI), embryo vitrification, and the use of AI in embryo selection.
  • O-1 – CLINICAL EVALUATION OF A MACHINE LEARNING MODEL FOR EMBRYO SELECTION: A DOUBLE-BLINDED RANDOMIZED COMPARATIVE READER STUDY
    (1)Reproductive Science Center of the San Francisco Bay Area, San Ramon, CA, (2)Alife Health, Inc., Cambridge, MA, (3)Alife Health, Inc., (4)Alife Health, Inc., San Francisco, CA, (5)CCRM Fertility, Lone Tree, CO, (6)IVF Florida Reproductive Associates, Margate, FL, (7)Ovation Fertility, Austin, TX
    (1)Ovation Fertility, San Antonio, TX, (2)Life Whisperer Diagnostics Inc (a subsidiary of Presagen), San Francisco, CA, (3)Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Adelaide, SA, Australia, (4)IVIRMA Global, Valencia, Spain, (5)IVI Foundation - La Fe Health Research Institute, Valencia, Comunidad Valenciana, Spain, (6)IVF Florida Reproductive Associates, Margate, FL, (7)Shady Grove Fertility, Rockville, MD, (8)Presagen and Life Whisperer, Adelaide, SA, Australia, (9)San Francisco Bay Area, Los Gatos, CA
    (1)Alife Health, Inc., San Francisco, CA, (2)Alife Health, Inc., (3)Boston IVF, Waltham, MA, (4)IVF Florida Reproductive Associates, Margate, FL, (5)Ovation Fertility, Austin, TX, (6) Reproductive Science Center of the San Francisco Bay Area, San Ramon, CA

Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States

Retrieved on: 
Thursday, January 26, 2023

PRIME-CKD is funded by Horizon Europe, the European Union’s key funding program for research and innovation.

Key Points: 
  • PRIME-CKD is funded by Horizon Europe, the European Union’s key funding program for research and innovation.
  • The total budget of the project is $10 million over a projected five-year period with approximately 10% of the budget targeted for commercial translation activities to be undertaken by Renalytix.
  • The consortium brings together leading experts from 11 academic institutions, together with partners from patient representative foundations and regulatory agencies.
  • The PRIME-CKD consortium will further develop the evidence-based tools and roadmap to unlock the potential of precision medicine in the management of CKD.

Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing

Retrieved on: 
Thursday, July 21, 2022

We are thrilled to be part of this consortium to support the continued innovation of cell therapy manufacturing processes, said Edward Samuel, EVP, Technical Operations at Achilles Therapeutics.

Key Points: 
  • We are thrilled to be part of this consortium to support the continued innovation of cell therapy manufacturing processes, said Edward Samuel, EVP, Technical Operations at Achilles Therapeutics.
  • Most cell therapy manufacturing platforms do not provide sufficient real-time data during production which can limit proactive decision making and reduce overall scalability.
  • This consortium will collaborate on the development of a proof-of-concept, first-in-class, smart bioprocessing manufacturing platform for personalized cell therapies that aims to incorporate advanced inline spectroscopic sensors and smart machine-learning process control systems.
  • The project, named SMARTER, will be conducted by a team of world-leading, interdisciplinary scientists from the consortium with expertise in cancer immunotherapy, bioinformatics, cell therapy bioprocess engineering, metabolomics and advanced sensor development.

The Valencian International University contracts the services of eKYC Onboarding from Lleida.net

Retrieved on: 
Tuesday, December 29, 2020

MADRID, Dec. 29, 2020 /PRNewswire/ -- The Valencian International University (VIU) has contracted the eKYC Onboarding services from Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) for the identification of its customers and students.

Key Points: 
  • MADRID, Dec. 29, 2020 /PRNewswire/ -- The Valencian International University (VIU) has contracted the eKYC Onboarding services from Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) for the identification of its customers and students.
  • eKYC Onboarding's platform is Lleida.net's proprietary platform created to allow for identification by videoconference in onboarding processes.
  • Developed especially for the financial sector, it is also used by educational and telecommunications companies.
  • Created in 2008, the Valencian Internacional Universitydelivers a large part of its classes by videoconference, emulating a face-to-face class through the Internet.

The Valencian International University contracts the services of eKYC Onboarding from Lleida.net

Retrieved on: 
Tuesday, December 29, 2020

MADRID, Dec. 29, 2020 /PRNewswire/ -- The Valencian International University (VIU) has contracted the eKYC Onboarding services from Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) for the identification of its customers and students.

Key Points: 
  • MADRID, Dec. 29, 2020 /PRNewswire/ -- The Valencian International University (VIU) has contracted the eKYC Onboarding services from Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) for the identification of its customers and students.
  • eKYC Onboarding's platform is Lleida.net's proprietary platform created to allow for identification by videoconference in onboarding processes.
  • Developed especially for the financial sector, it is also used by educational and telecommunications companies.
  • Created in 2008, the Valencian Internacional Universitydelivers a large part of its classes by videoconference, emulating a face-to-face class through the Internet.